Literature DB >> 25817349

In vitro protective effect of atorvastatin against ionizing radiation induced genotoxicity in human lymphocytes.

S J Hosseinimehr1, M Izakmehri2, A Ghasemi3.   

Abstract

Atorvastatin (AT) is widely used as a medication for treatment of hypercholesterolemia. Recent studies showed that AT enhanced cell toxicity induced by ionizing radiation in cancerous cells. In this study, the radioprotective effect of AT was investigated against genotoxicity induced by ionizing radiation in human blood lymphocytes. Peripheral blood samples were collected from human volunteers and incubated with AT at different concentrations (0.05, 0.1, 1, or 10 μM) for two hours. The whole blood was exposed to X-ray at dose 1.5 Gy. Lymphocytes were cultured with mitogenic stimulation to determine the micronuclei in cytokinesis blocked binucleated lymphocyte. AT exhibited a significant decreasing in the frequency of micronuclei in human lymphocytes exposed to ionizing radiation, as compared to with similarly irradiated lymphocytes without AT treatment. The maximum protection and higher decreasing in frequency of micronuclei was observed at 10 μM of AT (68% decrease), providing maximal protection against ionizing radiation. This data is promising for protection human normal cells from the genetic damage induced by ionizing irradiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25817349

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.

Authors:  Hamiyet Donmez-Altuntas; Fahri Bayram; Ayse N Coskun-Demirkalp; Osman Baspınar; Derya Kocer; Peter P Toth
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-19

2.  Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model.

Authors:  Maedeh Hamzeh; Seyed Jalal Hosseinimehr; Ali Reza Khalatbary; Hamid Reza Mohammadi; Ayat Dashti; Fereshteh Talebpour Amiri
Journal:  Res Pharm Sci       Date:  2018-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.